Stem Cell Banking Market Size and Trends
Global stem cell banking market is estimated to be valued at USD 6.50 Bn in 2025 and is expected to reach USD 17.00 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.
To learn more about this report, Request sample copy
Key Takeaways
Market Overview
Global stem cell banking market is witnessing growth due to growing awareness about the therapeutic potential of stem cells. Increasing investment by government and private companies in R&D activities for developing novel stem cell therapy and drugs also drives the market growth. Advancements in regenerative medicines using stem cells offer lucrative opportunities for market players. Moreover, rising focus on personalized medicine boosts demand for private and public cord blood banking services.
Current Events and Its Impact
Current Events |
Description and its impact |
Geopolitical Factors in Biosecurity |
|
Major Regulatory Shifts in EU ATMP Oversight (2025 Implementation) |
|
Emerging Market Capacity Expansion |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Reimbursement Scenario for Stem Cell Transplantation in Medicare Beneficiaries with Multiple Myeloma
In the context of Medicare beneficiaries with multiple myeloma undergoing hematopoietic stem cell transplantation (HCT), reimbursement and patient financial responsibility vary depending on whether the procedure is performed in an inpatient or outpatient setting.
Growing adoption of umbilical cord stem cell banking Drives segment growth
Umbilical cord stem cell segment is estimated to hold 44.0% of the market share in 2025, owing to rising adoption rates among expectant parents. Umbilical cord stem cells show high potential for treatments across a wide range of diseases. Compared to embryonic stem cells which face ethical issues, umbilical cord stem cells are more acceptable to the general public. Banking of umbilical cord stem cells is a non-invasive procedure that takes place immediately after childbirth. In recent years, awareness about cord blood banking and its potential benefits has grown substantially through effective marketing strategies of industry players. Many hospitals now promote cord blood collection and storage services to expecting families. Expectant parents are now turning towards umbilical cord stem cell banking because of its promise to cure multiple diseases. For example, Michael and Samantha Welch spoke of their good experience with cord blood banking services, which detailed how it could be used to improve their child's health in the future. Umbilical cord stem cells have proved to be promising in curing various diseases. Research in The Lancet proved that the reinfusion of umbilical cord blood cells into extremely premature infants can shield them from brain damage, bringing hope to neonatal health. This is further accelerating the stem cell banking market growth revenue.
Collection & transportation dominates owing to the rising number of banking facilities
Service Type segment is sub-segmented into collection and transportation, processing, analysis, storage. Collection and transportation segment is estimated to hold 33.3% of the market share in 2025. As the number of cord blood and tissue banking facilities increases across major markets, the need for efficient collection and transport logistics is growing. Proper collection and timely transport of stem cell units from hospitals or collection centers to the processing labs determine the viability and quality of the samples stored. Most leading banking service providers have established elaborate collection networks within 48-72 hours of childbirth to preserve maximum cell viability. These provide collection kits to partner hospitals and train medical staff to properly retrieve and package the umbilical cord and placental blood. Specialized cold chain transportation systems help maintain temperature stability during transit. A good example of the logistics challenges in stem cells was when a life-saving stem cell transplant for a patient with leukemia in Brisbane, Australia, was at risk. The flight that delivered the stem cells was diverted by Cyclone Alfred, posing a risk to the timely delivery of the stem cells. A team effort comprising ground transport delivered the cells to the hospital just as the viability window closed, highlighting the importance of effective logistics in stem cell treatments. These factors are further accelerating the stem cell market demand.
Rising Incidence of Leukemia Boosting Application in Stem Cell Therapies
Application segment is sub-segmented into leukemia, diabetes, lymphoma, cerebral palsy, thalassemia, others. Leukemia segment is estimated to hold 44.3% of the market share in 2025 due to rising patient pool. Leukemia refers to cancers affecting blood-forming tissues of the body. It is one of the most common types of cancers worldwide and a leading cause of cancer mortality. According to WHO, incidence rates of both acute and chronic leukemia have increased over the past decades. While conventional treatment options provide remission, relapse rates are high necessitating improvement. Stem cell transplantation has emerged as an effective alternative offering long term remission for leukemia patients. Harvested stem cells from cord blood or bone marrow are reconstituting patients' destroyed bone marrow during treatment. Researchers are also exploring new cellular therapies using gene-edited stem cells to target cancerous cells. Rising leukemia cases directly increase the demand for hematopoietic stem cell transplantation as a curative option, driving the segment growth. Recent research has widened the donor pool for stem cell transplants. A revolutionary clinical trial at the Huntsman Cancer Institute used stem cells from deceased donors, bringing new hope to patients who don't have available living donors. This technique holds great promise for significantly decreasing wait times and improving access to life-saving therapies.
Regional Insights
To learn more about this report, Request sample copy
North America Stem Cell Banking Market Analysis and Trends
North America remains the dominant region in the global stem cell banking market and is estimated to hold 40.8% of the market share in 2025 With a thriving biotech sector and widespread promotion of stem cells for medical therapies. Stringent regulations have provided stability for commercial operations while simultaneously encouraging important research. Many innovative clinics across the U.S. offer stem cell therapies and transplants. Moreover, various medical labs across the region are expanding their services, which is further acting as a growth inducing factor. In June 2024, Acorn Biolabs, a biotechnology startup based in Toronto that assists customers in freezing their stem cells for potential regenerative medicine treatments, announced it has raised around USD 8 million CAD in Series A funding through several rounds of investment. This is further proliferating the stem cell banking market growth.
Asia Pacific Stem Cell Banking Market Trends
Asia Pacific has emerged as the fastest growing region in the global stem cell banking landscape. Countries like China, India, South Korea and Japan are rapidly developing their healthcare industries and stem cell research capabilities. With rising income levels and improving access to healthcare, more citizens are opting for stem cell collection and storage as a preventive healthcare measure. Governments in Asia are proactively supporting this sector through research funding and regulatory guidelines. Cities with large research universities have become biotech startup hubs. International banking firms are also strategically entering Asian markets and partnering with local banks as outbound medical tourism increases. As the adoption of novel therapies progresses in Asia, demand for stem cell services is anticipated to surge dramatically over the coming years. Medeze Group, a Thai-based stem cell banking and regenerative healthcare organization, was conferred the Industry Champions of the Year Award at the 2024 Asia Corporate Excellence & Sustainability (ACES) Awards. From being a stem cell storage company in 2010, the organization has grown to become a leader in longevity science, providing cutting-edge health solutions in Southeast Asia. Medeze has state-of-the-art facilities with NEBB-certified Class 10 Cleanrooms and maintains American Association of Blood Banks (AABB) standards. Interestingly, it was the first in Thailand to offer MSC storage for umbilical cord tissue and the world's first adipose tissue storage service.
India Stem Cell Banking Market Trends
The India stem cell banking market is gaining momentum owing to the increasing public awareness of stem cell therapies, rising prevalence of chronic diseases, and supportive government initiatives promoting research in regenerative medicine. Besides this, various brands across India expanding their services beyond stem cell procedure, which is further creating lucrative stem cell banking market growth opportunities. In August 2024, LifeCell launched AreoVeda, a skincare brand for pregnant women, new mothers, and newborns, with an e-commerce store. The initial product line targets pregnancy-related concerns like dryness, acne, and pigmentation, as well as baby issues such as diaper rash, eczema, and cradle cap.
Apart from this, the School of Tropical Medicine has launched the country’s first government-run stem cell preservation center, the cord blood bank. The stored stem cells can be utilized in the future for the treatment of the child or, when they grow into adulthood, to address congenital and genetic issues, as well as to treat various complex diseases that cannot be cured through conventional methods. This is further contributing to the stem cell banking market share.
United States Stem Cell Banking Market Trends
Public awareness campaigns and media coverage about the potential of stem cells to treat a variety of medical conditions, such as leukemia, anemia, and regenerative therapies for spinal cord injuries, have led to greater consumer interest. Memorial Sloan Kettering Cancer Center (MSK) and NMDP/Be The Match® have teamed up to launch the “American Symphony: Become a Lifesaver” campaign. The initiative aims to boost blood stem cell and marrow donor registrations, focusing on increasing access to transplants for ethnically diverse communities. These factors are positively influencing the United States stem cell banking market forecast.
Recent Developments
Stem Cell Banking Market Growth Drivers:
Increasing Research and Development for the Treatment of Diseases
Increasing research and development for the treatment of diseases is expected to propel the market growth. For instance, in May 2022, Xintela, a company that develops medical products in stem cell therapy and targeted cancer therapy, announced the result of study conducted for the company’s stem cell product XSTEM, after injection into a joint with damaged cartilage, and develop into cartilage cells and directly contribute to producing new cartilage tissue. This demonstrates that XSTEM has excellent potential to be a DMOAD (Disease Modifying Osteoarthritis Drug), a treatment that can prevent further degradation of the cartilage in osteoarthritis patients.
Market Opportunity – Growing Technological Advancements in Stem Cell Research
Advancements in stem cell research technologies are opening exciting new possibilities and promise hope for new therapies that could treat many incurable diseases. With recent breakthroughs, researchers are now able to direct stem cells to become specific cell types much more efficiently. This targeted differentiation ability allows scientists to create functional cell types like heart, nerve and pancreatic cells that could potentially replace those lost to injury or disease. Robust characterization techniques also allow detailed analysis of stem cell properties, improving quality control and helping maximize their therapeutic potential.
Market Report Scope
Stem Cell Banking Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 6.50 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 14.7% | 2032 Value Projection: | USD 17.00 Bn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Stem Cyte, Inc., CRYO-CELL INTERNATIONAL, INC., ViaCord, Cordlife Group Limited, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, Transcell Biolife Pvt. Ltd., Cordlife Group Limited, Covis Pharma, CSG Bio |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Analyst Opinion (Expert Opinion)
Market Segmentation
Sources
Primary Research Interviews from the Following Stakeholders
Databases & Institutional Sources
Magazines & Scientific Journals
News Outlets
Associations & Regulatory Bodies
Public Domain Sources
Proprietary Elements
Share
Share
About Author
Abhijeet Kale is a results-driven management consultant with five years of specialized experience in the biotech and clinical diagnostics sectors. With a strong background in scientific research and business strategy, Abhijeet helps organizations identify potential revenue pockets, and in turn helping clients with market entry strategies. He assists clients in developing robust strategies for navigating FDA and EMA requirements.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our ClientsUS Reciprocal Tax Impact Analysis On Stem Cell Banking Market
Stay updated on tariff changes with expert insights and timely information